Iovance Biotherapeutics Inc (IOVA)
13.63
+0.75
(+5.82%)
USD |
NASDAQ |
May 03, 16:00
13.58
-0.05
(-0.37%)
After-Hours: 20:00
Iovance Biotherapeutics Gross Profit Margin (Quarterly): -805.6% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -805.6% |
September 30, 2023 | -825.4% |
Date | Value |
---|---|
June 30, 2023 | -761.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-825.4%
Minimum
Sep 2023
-761.3%
Maximum
Jun 2023
-797.4%
Average
-805.6%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
QuidelOrtho Corp | 51.35% |
Perspective Therapeutics Inc | -- |
Electromed Inc | 77.03% |
Xtant Medical Holdings Inc | 60.97% |
Asensus Surgical Inc | 21.47% |
Gross Profit Margin (Quarterly) Related Metrics
Profit Margin (Quarterly) | -24.15K% |
Operating Margin (Quarterly) | -25.16K% |